|
Post by mytakeonit on May 26, 2023 13:05:08 GMT -5
Heading into a holiday ... so normal.
|
|
|
Post by peppy on May 26, 2023 13:12:51 GMT -5
Heading into a holiday ... so normal. I think it is irritating. My plan was for MNKD share price to follow the Nasdaq up to test the 13,000. Heh.
|
|
|
Post by peppy on May 26, 2023 15:12:07 GMT -5
MNKD Nasdaq real time volume, 2,483,491 shares. $4.54. -0.01 (-0.2198%) An uninspiring weekly candle for MNKD price closing on it's 20 week MA. All MNKD's MA below price. Down 7 cents on the week on low volume. schrts.co/yEkDZmNPMNKD daily, schrts.co/mkfDDxWH$COMPQ weekly. Testing resistance here at the 100 week. The 13,000 was the head and shoulders neckline, so that type of resistance. schrts.co/UEDNZNSp$SPX. schrts.co/pwWpcXxZDitto, the $compq, at resistance.
|
|
|
Post by prcgorman2 on May 26, 2023 23:35:34 GMT -5
Thank you peppy. We’re still looking good from a monthly perspective. Fingers crossed for higher floors and higher highs.
|
|
|
Post by Chris-C on May 27, 2023 15:20:45 GMT -5
Heading into a holiday ... so normal. Unfortunately, tediously normal. Someday, things will be different, (he said, wishfully).
|
|
|
Post by prcgorman2 on May 30, 2023 8:35:55 GMT -5
70,000 shares in first 5 minutes. Up 9 cents. Fun way to start a short week.
|
|
|
Post by peppy on May 30, 2023 11:03:24 GMT -5
at 2 1/2 hours of trade, MNKD volume, 1,000,792 Avg. Volume 3,272,403
$4.50. -0.04 (-0.8811%)
relatively high volume for MNKD this time of day.
Volume 1,179,657 on the half. $4.48. -0.06
|
|
|
Post by awesomo on May 30, 2023 11:32:13 GMT -5
70,000 shares in first 5 minutes. Up 9 cents. Fun way to start a short week. This did not age well...
|
|
|
Post by prcgorman2 on May 30, 2023 12:05:52 GMT -5
70,000 shares in first 5 minutes. Up 9 cents. Fun way to start a short week. This did not age well... Fact (so far anyway). Sector appears down too. Dow sucking air. NASDAQ positive but contracting.
National debt hangover anyone? The Congressional Budget Office predicts Public debt will exceed 98% of GDP in 2023. www.cbo.gov/publication/58946 This hangover is nothing compared to what's possible if the US manages to default on it's interest payments.
|
|
|
Post by mytakeonit on May 30, 2023 12:48:40 GMT -5
National Debt Hangover ... I'll never quit wineing But, that's mytakeonit
|
|
|
Post by peppy on May 30, 2023 15:22:35 GMT -5
at 2 1/2 hours of trade, MNKD volume, 1,000,792 Avg. Volume 3,272,403 $4.50. -0.04 (-0.8811%) relatively high volume for MNKD this time of day. Volume 1,179,657 on the half. $4.48. -0.06 MNKD Nasdaq summary volume, 2,674,190 Avg. Volume 3,272,403 $4.43. -0.11 (-2.42%) outside day. schrts.co/NnaehbYM
|
|
|
Post by agedhippie on May 30, 2023 17:01:40 GMT -5
Traders are trying their best to keep us humble while we await the next quarterly. Many of us would rather not hear good news about MNKD, because it so dependably predicts a share price decline. Meanwhile, inexplicably, LQDA rises, with a SP 20% higher than MNKD. Wall street: You have to love it. It is so quintessentially tilted in favor of game playing. There was news that LQDA has secured financing based on equity, winning litigation on patents, and royalties of sales. Plus they have misleading statements about dosing capabilities with their inhaler. I am curious what misleading statements they are putting out about their inhaler. (LQDA dropped twice as much as MNKD today )
|
|
|
Post by mymann on May 30, 2023 19:29:38 GMT -5
What is it about mnkd that does not get fair value while lqda seems to be over valued? This injustice has been going on for over a decade. Is our management team so bad since Al passed that wall street fails to analyze the potential value?
|
|
|
Post by prcgorman2 on May 30, 2023 19:58:30 GMT -5
The MannKind story has never been better. 3 FDA-approved products bringing in revenue. Promising drugs in the pipeline with one, clofazimine, in an accelerated orphan drug approval process to treat Non-Tuberculosis Mycobacteria (NTM) infection, and United Therapeutics and Wall Street analysts raising their guidance on sales of Tyvaso DPI. LQDA was down more than MNKD today but I don’t care if they’re up or down. Even the most optimistic estimates are a minor amount of the Tyvaso DPI market. And, I assume UTHR and analysts have “baked in” LQDA as a competitor. I remain largely unconcerned while we wait for goodness to materialize.
|
|
|
Post by cretin11 on May 30, 2023 21:17:28 GMT -5
What is it about mnkd that does not get fair value while lqda seems to be over valued? This injustice has been going on for over a decade. Is our management team so bad since Al passed that wall street fails to analyze the potential value? Management team is always something that Wall Street takes into account.
|
|